EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function

Edward J A Douglas, Brandon Marshall, Arwa Alghamadi, Erin A Joseph, Seána Duggan iD, Serena Vittorio iD, Laura De Luca, Michaela Serpi iD, Maisem Laabei iD

ACS Infectious Diseases · 2023

DOI: 10.1021/acsinfecdis.3c00250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Edward J A Douglas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Bath, Bath BA2 7AY, U.K. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Department of Health, Medical Research Council Centre for Medical Mycology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnimalsAnti-Bacterial AgentsMammalsOxadiazolesStaphylococcus aureusLipopolysaccharidesTeichoic Acids

Stichwörter der Autor:innen

1,3,4 oxadiazoleStaphylococcus aureusantimicrobial resistancedrug discoverylipoteichoic acid inhibitors

Substanzen

Anti-Bacterial AgentsOxadiazoles1,3,4-oxadiazolelipoteichoic acidLipopolysaccharidesTeichoic Acids

Autor:innen und Institutionen

  • Department of Life Sciences, University of Bath, Bath BA2 7AY, U.K.
  • School of Chemistry, Cardiff University, Cardiff CF10 3AT, Wales, U.K.
  • Medical Research Council Centre for Medical Mycology at the University of Exeter, University of Exeter, Exeter EX4 4DQ, U.K.
  • Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina I-98125, Italy.

ORCID-Profile: Seána Duggan, Serena Vittorio, Michaela Serpi, Maisem Laabei

Förderung

  • Medical Research Council
  • Department of Health
  • Medical Research Council Centre for Medical Mycology
  • Microbiology Society
  • Academy of Medical Sciences
  • National Institute for Health and Care Research
  • University of Exeter
  • University of Bath

Zitieren

APA

Douglas, E. J. A., Marshall, B., Alghamadi, A., Joseph, E. A., Duggan, S., Vittorio, S., De Luca, L., Serpi, M., & Laabei, M. (2023). Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00250

Vancouver

Douglas EJA, Marshall B, Alghamadi A, Joseph EA, Duggan S, Vittorio S, et al. Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.3c00250

BibTeX
@article{Douglas2023,
  author = {Douglas, Edward J A and Marshall, Brandon and Alghamadi, Arwa and Joseph, Erin A and Duggan, Seána and Vittorio, Serena and De Luca, Laura and Serpi, Michaela and Laabei, Maisem},
  title = {Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function},
  journal = {ACS Infectious Diseases},
  year = {2023},
  doi = {10.1021/acsinfecdis.3c00250}
}
Kostenlos starten →